Beta Drugs Ltd

NSE: BETA · BSE: 531481 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹1,871.00
Market cap: ₹2,074 Cr
Revenue (annual): ₹384.8 Cr
Net profit (annual): ₹41.48 Cr
P/E (TTM): 40.0×Sector 43.8×
Promoter holding: 58.91%-0.19% QoQ
FII holding: 1.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 3 Board Meeting Date 3 Other Announcement 2 Fund Raise 2 Board Meeting Outcome 2 Annual General Meeting 2 Results Correction 1 Price Movement Clarification 1 Management Change 1 Capital Structure Change 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

25 May 2026 12:09 IST NSE

Fund Raise

Beta Drugs Fund Raise

Beta Drugs Limited allotted 6,65,314 equity shares upon conversion of CCDs on May 25, 2026. This increases the company's paid-up share capital to ₹11.09 Crore.

Open announcement → Read the filing ↗

14 May 2026 16:12 IST NSE

Fund Raise

Beta Drugs Fund Raise of ₹117 Cr

Beta Drugs Limited reported utilization of ₹117.01 Crore raised through preferential issues. The Monitoring Agency confirms funds were deployed for subsidiary upgradation and R&D.

Value: ₹117.0 Cr

Open announcement → Read the filing ↗